Beruflich Dokumente
Kultur Dokumente
DOI 10.1007/s10995-010-0679-3
C. A. Powers
Division of Pharmacoepidemiology and Pharmacoeconomics,
Brigham and Womens Hospital, Boston, MA, USA
J. Zapka
Department of Biostatistics, Bioinformatics and Epidemiology,
Medical University of South Carolina, Charleston, SC, USA
S. Phelan
Department of OB/GYN, University of New
Mexico-Albuquerque, Albuquerque, NM, USA
zcan
T. O
Department of OB/GYN, University of Rochester Medical
Center, Rochester, NY, USA
K. B. Biello
Department of Epidemiology and Public Health,
Yale University, New Haven, CT, USA
J. ODonnell
Department of Medicine, Dartmouth Medical School,
Hanover, NH, USA
A. Geller (&)
Division of Public Health Practice, Harvard School of Public
Health, Landmark Center, 401 Park Drive, Third Floor East,
Boston, MA 02115, USA
e-mail: ageller@hsph.harvard.edu
Introduction
An estimated 18% of pregnant women ages 1844 in the
US smoke [1]. The US Surgeon General and the American
College of Obstetricians and Gynecologists (ACOG) have
determined that smoking during pregnancy is the most
modifiable risk factor for poor birth outcomes [2], and
ACOG includes tobacco use on its list of gender-specific
risks [3]. The impact of smoking during pregnancy,
including increased rates of fetal mortality and morbidity,
has been well documented [4]. Intrauterine exposure to
maternal smoking accounts for 20% of low birth-weight
babies, 8% of pre-term deliveries, and 5% of prenatal
deaths nationwide [5]. Women who use tobacco are also
twice as likely to be diagnosed with cervical cancer and
40% more likely to be diagnosed with breast cancer [69].
Smoking rates during pregnancy are estimated as high as
25% overall, with rates exceeding 35% for women on
Medicaid [10, 11]. Relapse rates range from 70 to 85%
123
1154
123
Methods
Participants
We obtained a list of current clerkship directors and
assistant directors from the Association of Professors of
Gynecology and Obstetrics (hereafter directors and assistant directors will be referred to as directors).
Procedure
In 2007, we mailed a 28-question survey to directors at US
medical school OB/GYN clerkship programs. Initial surveys were sent via mail. Non-respondents received email
surveys. We made a maximum of four attempts via mail
and email to reach participants. The research procedures
and survey were approved by Institutional Review Boards
at Boston University and the Harvard School of Public
Health.
Instruments and Measures
After ascertaining the respondents current position (e.g.,
clerkship director or assistant clerkship director), years of
service, duration of each OB/GYN clerkship block (in
weeks), number of clerkship sites, and number of OB/GYN
patients seen by medical students during a rotation, we
divided the survey into sections representing five domains
traditionally used to assess and plan for new programs in
substance abuse and tobacco for physicians-in-training,
including medical students and residents [3135].
1155
Results
Of the 129 US medical schools with an OB/GYN clerkship
program, surveys were completed by OB/GYN clerkship
directors at 70% (90/129) of the schools, with 57 returned
via regular mail and 33 via e-mail. Eighty-eight percent of
respondents were clerkship directors and the rest were
assistant clerkship directors.
Respondents Position and Years of Service
On average, respondents had served 5 years in their current
capacity with a range of \123 years.
Clerkship Program Structure and Setting
Sixty-one percent of the clerkships lasted 6 weeks, 26%
8 weeks, 7% 4 weeks and 6 % other. Seventy-three
percent of programs had at least 24 clinical rotation sites.
Respondents reported that 74% of students see at least 21
gynecology patients and 88% see at least 21 obstetrics
patients during a rotation.
Tobacco Cessation Teaching and Tobacco Control
Policies
Nine percent (8/90) of directors reported having at least
15 min of dedicated teaching time for improving tobacco
cessation skills. Of these, only one program used role plays
for skills training while the remainder (n = 7) used didactic
123
1156
Refer
Yes (%)
No (%)
Total (%)
Intervene
Yes
32.9
39.0
72.0
No
9.8
18.3
28.0
Total
42.7
57.3
100.0
74
74
60
50
40
30
56
45
35
34
33
32
20
10
0
123
Discussion
With 16,000 medical students completing OB/GYN
clerkship programs each year, a unique opportunity exists
1157
123
1158
11.
12.
13.
14.
15.
16.
17.
18.
References
1. Centers for Disease Control. (2010). Smoking & tobacco use.
Fact sheet women and tobacco. Office on Smoking and Health.
Centers for Disease Control. http://www.cdc.gov/tobacco/
data_statistics/fact_sheets/populations/women/. Accessed 07/15/
2010.
2. Hamilton, B. E., Martin, J. A., & Ventura, S. J. (2010). Births:
Preliminary data for 2008. National vital statistics reports (Vol.
58, No 16). Hyattsville, MD: National Center for Health Statistics. Released 6 April 2010.
3. APGO. (2001). Womens Healthcare competencies sample
learning objectives for UGME. http://www.apgo.org/binary/
Comp.pdf. Accessed 15 July 2010.
4. Melvin, C., Dolan-Mullen, P., Windsor, R., Whiteside, H., &
Goldenberg, R. (2000). Recommended cessation counseling for
pregnant women who smoke: A review of the evidence. Tobacco
Control, 9(Suppl. 3), iii80iii84.
5. US Department of Health and Human Services, Surgeon Generals
Report. (2001). Women and smoking. http://www.surgeongeneral.
gov/library/womenandtobacco/. Accessed 7/15/2010.
6. American Cancer Society (2009) What are the risk factors for
cervical cancer? http://www.cancer.org/Cancer/CervicalCancer/
DetailedGuide/cervical-cancer-risk-factors. Accessed 7/15/2010.
7. Dobson, R. (2002). Risk of breast cancer increases with number
of years smoking. BMJ, 325, 298.
8. Gunnell, A. S., Tran, T. N., Torrang, A., Dickman, P. W., &
Sparen, P. (2006). Synergy between human papilloma virus type
16 in cervical cancer in situ development. Cancer Epidemiology,
Biomarkers and Prevention, 15(11), 21412147.
9. Li, C. I., Malone, K. E., & Daling, J. R. (2005). The relationship
between various measures of cigarette smoking and risk of breast
cancer among older women 6579 years of age (United States).
Cancer Causes and Control, 16(8), 975985.
10. Geller, A. C., Brooks, D. R., Powers, C. A., Brooks, K. R.,
Rigotti, N. A., Bognar, B., et al. (2008). Tobacco cessation and
prevention practices reported by second and fourth year students
123
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
1159
35. Springer, C. M., Tannert Niang, K. M., Matte, T. D., Miller, N.,
Bassett, M. T., & Frieden, T. R. (2008). Do medical students
know enough about smoking to help their future patients?
Assessment of New York City fourth-year medical students
knowledge of tobacco cessation and treatment for nicotine
addiction. Academic Medicine, 83, 982989.
36. Quinn, V. P., Stevens, V. J., Hollis, J. F., Rigotti, N. A., Solberg,
L. I., Gordon, N., et al. (2005). Tobacco-cessation services and
patient satisfaction in nine nonprofit HMOs. American Journal of
Preventive Medicine, 29, 7784.
37. Jordan, T. R., Dake, J. A., & Price, J. H. (2006). Best practices for
smoking cessation in pregnancy: Do obstetrician/gynecologists
use them in practice? Journal of Womens Health, 15(4),
400441.
38. Stead, L. F., Bergson, G., & Lancaster, T. (2008). Physician
advice for smoking cessation. Cochrane Database of Systematic
Reviews, 16(2), CD000165.
39. State Medicaid coverage for tobacco-dependence treatment
United States, 2006. (2008). MMWR Morb Mortal Wkly Rep,
57(5), 117122.
123